This paper focused on the early intervention of rTMS on AD‐related pathological indices, especially of Aβ deposition and phosphorylated Tau, to explore the molecular mechanism by which rTMS enhanced the cognitive function of AD mice. Here, MAPT is linked to Alzheimer disease.